Table 1 General information of childhood ALL patients with and without TLS.

From: Clinical characteristics of tumor lysis syndrome in childhood acute lymphoblastic leukemia

 

Without TLS

5458 (N%)

With TLS

79 (N%)

OR (95% CI)c

Age

1 to 10

4689 (99.0)

45 (1.0)

1.00

≥ 10

689 (96.2)

27 (3.8)

2.2 (1.33.8)

< 1

80 (92.0)

7 (8.0)

8.6 (3.022.2)

Sex

Female

2232 (99.0)

23 (1.0)

1.00

Male

3226 (98.3)

56 (1.7)

1.5 (0.9–2.5)

WBCa (× 109/L)

< 50

4351 (99.2)

36 (0.8)

1.00

≥ 50

1107 (96.3)

43 (3.7)

2.6 (1.64.5)

Immunophenotype

B

4979 (99.2)

42 (0.8)

1.00

T

479 (92.8)

37 (7.2)

4.7 (2.68.8)

t(12;21)(ETV6-RUNX1)

Present

1067 (99.5)

5 (0.5)

1.00

Absent

4391 (98.3)

74 (1.7)

0.9 (0.3–3.0)

t(1;19)(TCF3-PBX1)

Absent

5185 (98.6)

74 (1.4)

1.00

Present

273 (98.2)

5 (1.8)

0.6 (0.2–1.8)

t(9;22)(BCR-ABL1)

Absent

5231 (98.6)

76 (1.4)

1.00

Present

227 (98.7)

3 (1.3)

1.4 (0.5–6.0)

KMT2A rearrangement

Absent

5285 (98.6)

74 (1.4)

1.00

Present

173 (97.2)

5 (2.8)

1.3 (0.5–4.3)

Chromosome

Hyperdiploidy > 50

789 (99.4)

5 (0.6)

1.00

Othersb

4669 (98.4)

74 (1.6)

0.9 (0.4–2.7)

Risk

LR

2885 (99.6)

11 (0.4)

1.00

IR/HR

2573 (97.4)

68 (2.6)

1.8 (0.7–4.4)

  1. aMaximum number of WBC.
  2. bSeven missing values of Chromosome karyotype were classified as “others”.
  3. cCalculated by multivariable logistic regression analyses.
  4. Bold values denote significant difference between groups.